A Phase II Study of Sunitinib in Recurrent or Progressive Brain Tumors in Pediatric and Young Adult Patients

Grant

Total Award Amount

  • 20300.00
  • Direct Costs

  • 16111.00
  • Sponsor Award Id

  • Contributor

  • Gregory Friedman M.D.   Investigator